Lv1
100 积分 2025-04-16 加入
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
1个月前
已完结
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
1个月前
已完结
Hemophagocytic Lymphohistiocytosis
1个月前
已完结
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
1个月前
已完结
Acute graft-versus-host disease
2个月前
已完结
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
2个月前
已关闭
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions
2个月前
已完结
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
2个月前
已关闭
Comprehensive pharmacovigilance analysis of belumosudil: A real-world study using the FDA adverse event reporting system (FAERS)
2个月前
已完结
Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy
2个月前
已完结
皖公网安备34019202002308
